| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 03/05/2008 | EP1625129B1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
| 03/05/2008 | CN101137657A Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists |
| 03/05/2008 | CN101137645A Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 03/05/2008 | CN101137436A Base stable ionic liquids |
| 03/05/2008 | CN101137388A Anti-adhesion composites and methods os use thereof |
| 03/05/2008 | CN100372853C Metal porphyrin nanotube and nanoline and their preparation process |
| 03/05/2008 | CN100372852C Synthesis of temozolomide and analogs |
| 03/05/2008 | CN100372851C Fused pyrimidine derivatives with CRF activity |
| 03/05/2008 | CN100372850C Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/05/2008 | CN100372849C Pyrrolo pyrimidine compounds as inhibitor of cysteine protease |
| 03/05/2008 | CN100372844C 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 03/05/2008 | CN100372536C Tablets quickly disintegrated in oral cavity |
| 03/04/2008 | US7339058 Process for the preparation of N-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides |
| 03/04/2008 | US7339054 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine |
| 03/04/2008 | US7338957 Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs |
| 03/04/2008 | US7338955 Medicament for treatment of neuropathies |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2008024151A2 Salts and co-crystals of pyrazolopyrimidine compounds, compositions thereof and methods for their production and use |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008023239A1 Pyrimidone compounds as gsk-3 inhibitors |
| 02/28/2008 | WO2008022747A1 Tricyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/28/2008 | WO2008022396A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/28/2008 | WO2008003766A3 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
| 02/28/2008 | WO2008000692A3 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 02/28/2008 | WO2007150001A8 Pyrro[1,2-b]pyridazinone compounds |
| 02/28/2008 | WO2007139967A3 Triazole compounds that modulate hsp90 activity |
| 02/28/2008 | WO2007025043A3 Seven-membered ring nucleosides |
| 02/28/2008 | US20080051579 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051425 Vinorelbine derivatives |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051421 pyrazolo- and imidazo-pyrimidine derivatives; for anxiety and pain, neurodegenerative disorders; 8-Pyridin-4-yl-4-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidine |
| 02/28/2008 | US20080051420 New Compounds 317 |
| 02/28/2008 | US20080051419 Amine derivatives useful as anticancer agents |
| 02/28/2008 | US20080051414 Protein Kinase Inhibitors |
| 02/28/2008 | US20080051408 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders |
| 02/28/2008 | US20080051390 Such as 8-[3-(2-Fluoropyridin-3-yl)phenyl]-8-pyridin-4-yl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amine; amyloid disorders, Alzheimer's disease, Down's syndrome |
| 02/28/2008 | US20080051389 mimetics of the Smac peptide, used for the treatment of cancer and autoimmune disorders |
| 02/28/2008 | US20080051387 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 02/28/2008 | US20080050760 Compositions and methods to co-localize luminophores with luminescent proteins |
| 02/28/2008 | US20080048185 Field effect transistor and method of manufacturing the same |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | CA2660169A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1892239A1 Inhibitors of cytosolic phospholipase A2 |
| 02/27/2008 | EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| 02/27/2008 | EP1891075A1 Tricyclic spiro derivatives as crth2 modulators |
| 02/27/2008 | EP1891074A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/27/2008 | EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| 02/27/2008 | EP1891072A2 Substituted 7, 8-dihydro-1h-pyrimido[4,5-b][1,4] diazepin-4-amines as kinase inhibitors |
| 02/27/2008 | EP1891069A1 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 02/27/2008 | EP1891048A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders |
| 02/27/2008 | EP1891021A1 Aspartyl protease inhibitors |
| 02/27/2008 | EP1689752B1 Pyrazolopyrimidines |
| 02/27/2008 | EP1633364B1 Processes for the production of sildenafil base and citrate salt |
| 02/27/2008 | EP1558616B1 Meso-substituted porphyrins |
| 02/27/2008 | EP1149105B1 4,5-pyrazinoxindoles as protein kinase inhibitors |
| 02/27/2008 | EP1039906B1 metal complexes with antibacterian and fungicidal effects |
| 02/27/2008 | EP0896578B1 NOVEL IMIDAZO[1,5-c]QUINAZOLINES; A NEW CLASS OF GABA BRAIN RECEPTOR LIGANDS |
| 02/27/2008 | CN101133062A Method of reducing alpha, beta unsaturated ketones in opioid compositions |
| 02/27/2008 | CN101133061A Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133059A 5,6-dialkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds |
| 02/27/2008 | CN101133058A 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound |
| 02/27/2008 | CN101133057A Triazolophthalazines |
| 02/27/2008 | CN101133056A Anti-tumor compounds |
| 02/27/2008 | CN101133055A Compositions and methods for treatment of cancer |
| 02/27/2008 | CN101133029A Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/27/2008 | CN101130544A Chemical synthesis method for epinastine |
| 02/27/2008 | CN101130526A Aryl carbonyl derivatives as therapeutic agents |
| 02/27/2008 | CN100371336C Pyrrole derivatives for treating diseases of cytokine mediated |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/26/2008 | US7335774 Quinolinone derivatives |
| 02/26/2008 | US7335769 Indoloazepines are useful for therapy of cancer by the inhibition of kinases CHK1 and CHK2; therapy of inflammatory diseases |
| 02/26/2008 | US7335768 using bis (phthalhydrazides) as glycoluril surrogates to control the size, shape and pattern of functional groups in curcubit forming reactions; form host-guest complexes |
| 02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/26/2008 | US7335656 Medical devices employing triazine compounds and compositions thereof |
| 02/26/2008 | US7335373 N-bromo- or chloro-substituted 7,7,9,9-tetramethyl-1,3,8-triazaspiro[4.5]decane-2,4-dione and 3-(3-trialkoxysilylpropyl) derivatives thereof; surface treatment to render antimicrobial |
| 02/21/2008 | WO2008021924A1 Pyrrolotriazine kinase inhibitors |
| 02/21/2008 | WO2008021859A1 Pyrrolotriazine kinase inhibitors |
| 02/21/2008 | WO2008021781A1 Triazolotriazines as kinase inhibitors |
| 02/21/2008 | WO2008021545A2 Modulators of muscarinic receptors |
| 02/21/2008 | WO2008021411A2 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
| 02/21/2008 | WO2008021410A2 Highly pure pemetrexed diacid and processes for the preparation thereof |
| 02/21/2008 | WO2008021405A1 Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
| 02/21/2008 | WO2008021385A2 Processes for preparing intermediates of pemetrexed |
| 02/21/2008 | WO2008020456A2 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 02/21/2008 | WO2008020455A2 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 02/21/2008 | WO2008019968A1 Non-nucleoside reverse transcriptase inhibitors |
| 02/21/2008 | WO2007150026A3 Purinone derivatives as hm74a agonists |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007141805A3 Novel process for the preparation of sildenafil citrate |
| 02/21/2008 | WO2007136692A3 Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-n-((1s)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts |
| 02/21/2008 | WO2007130860A3 Constrained compounds as cgrp-receptor antagonists |
| 02/21/2008 | US20080045724 Deuterated Polyimides and Derivatives Thereof |
| 02/21/2008 | US20080045713 Tetrahydroisoquinolinedione derivative intermediates for the hemisynthesis of ecteinascidin or other tetrahydroisoquinolinephenol compounds |
| 02/21/2008 | US20080045711 Crystalline forms of pemetrexed diacid and processes for the preparation thereof |
| 02/21/2008 | US20080045705 2-oxoethyl(1R)-4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-[[3,5-dimethyl-4-(phenylmethoxy)phenyl]methyl]-2-[4-(4-morpholinyl)-1-piperidinyl]-1-piperidinecarboxylate; coupling alpha -hydroxy-3,5-dimethyl-4-(phenylmethoxy)-phenylpropionic acid-monosodium salt with 1,3-benzodiazepin compound |
| 02/21/2008 | US20080045581 Ppar active compounds |
| 02/21/2008 | US20080045547 Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use |